- Home
- CODI vs SVRA Comparison
CODI vs SVRA Comparison
Compare CODI & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODI
- SVRA
- Stock Information
- Founded
- CODI 2005
- SVRA 2007
- Country
- CODI United States
- SVRA United States
- Employees
- CODI N/A
- SVRA N/A
- Industry
- CODI Home Furnishings
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CODI Consumer Discretionary
- SVRA Health Care
- Exchange
- CODI Nasdaq
- SVRA Nasdaq
- Market Cap
- CODI 480.0M
- SVRA 473.6M
- IPO Year
- CODI 2006
- SVRA N/A
- Fundamental
- Price
- CODI $7.34
- SVRA $3.04
- Analyst Decision
- CODI Buy
- SVRA Buy
- Analyst Count
- CODI 2
- SVRA 7
- Target Price
- CODI $26.00
- SVRA $5.57
- AVG Volume (30 Days)
- CODI 1.0M
- SVRA 1.1M
- Earning Date
- CODI 08-26-2025
- SVRA 08-13-2025
- Dividend Yield
- CODI 13.62%
- SVRA N/A
- EPS Growth
- CODI N/A
- SVRA N/A
- EPS
- CODI N/A
- SVRA N/A
- Revenue
- CODI $2,198,233,000.00
- SVRA N/A
- Revenue This Year
- CODI $8.09
- SVRA N/A
- Revenue Next Year
- CODI $7.62
- SVRA N/A
- P/E Ratio
- CODI N/A
- SVRA N/A
- Revenue Growth
- CODI 11.87
- SVRA N/A
- 52 Week Low
- CODI $5.98
- SVRA $1.89
- 52 Week High
- CODI $24.32
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- CODI 58.88
- SVRA 69.39
- Support Level
- CODI $6.64
- SVRA $2.43
- Resistance Level
- CODI $7.69
- SVRA $2.77
- Average True Range (ATR)
- CODI 0.35
- SVRA 0.20
- MACD
- CODI 0.12
- SVRA 0.04
- Stochastic Oscillator
- CODI 76.33
- SVRA 71.76
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.